Gábor Petővári

869 total citations · 1 hit paper
29 papers, 590 citations indexed

About

Gábor Petővári is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gábor Petővári has authored 29 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Gábor Petővári's work include Cancer, Hypoxia, and Metabolism (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer Cells and Metastasis (4 papers). Gábor Petővári is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer Cells and Metastasis (4 papers). Gábor Petővári collaborates with scholars based in Hungary, United States and France. Gábor Petővári's co-authors include Anna Sebestyén, Titanilla Dankó, Tamás Visnovitz, Ildikó Krencz, László Drahos, Lilla Turiák, Edit I. Buzás, Katalin Szabó-Taylor, Anett Mázló and András Försönits and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Gábor Petővári

28 papers receiving 587 citations

Hit Papers

Formation of a protein corona on the surface of extracell... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gábor Petővári Hungary 12 446 247 89 89 68 29 590
Johannes Voshol Switzerland 8 691 1.5× 278 1.1× 84 0.9× 52 0.6× 81 1.2× 10 791
Clayton Deighan United States 12 284 0.6× 186 0.8× 144 1.6× 58 0.7× 84 1.2× 13 444
Prakash Vempati United States 7 374 0.8× 121 0.5× 96 1.1× 74 0.8× 39 0.6× 7 601
Victor Ma China 9 889 2.0× 491 2.0× 90 1.0× 166 1.9× 101 1.5× 16 1.0k
Josefa Carrión-Navarro Spain 13 539 1.2× 376 1.5× 83 0.9× 77 0.9× 60 0.9× 18 713
Lizandra Jimenez United States 7 569 1.3× 375 1.5× 104 1.2× 79 0.9× 107 1.6× 13 708
Émilie Buache France 10 247 0.6× 142 0.6× 166 1.9× 64 0.7× 65 1.0× 14 521
Santiago Serrano Spain 12 409 0.9× 195 0.8× 227 2.6× 63 0.7× 70 1.0× 22 780
Joana Maia Portugal 7 633 1.4× 426 1.7× 87 1.0× 80 0.9× 105 1.5× 11 742
Xiaomou Wei China 9 737 1.7× 461 1.9× 70 0.8× 106 1.2× 181 2.7× 14 876

Countries citing papers authored by Gábor Petővári

Since Specialization
Citations

This map shows the geographic impact of Gábor Petővári's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gábor Petővári with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gábor Petővári more than expected).

Fields of papers citing papers by Gábor Petővári

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gábor Petővári. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gábor Petővári. The network helps show where Gábor Petővári may publish in the future.

Co-authorship network of co-authors of Gábor Petővári

This figure shows the co-authorship network connecting the top 25 collaborators of Gábor Petővári. A scholar is included among the top collaborators of Gábor Petővári based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gábor Petővári. Gábor Petővári is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dankó, Titanilla, Gábor Petővári, Gyula Végső, et al.. (2024). Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas. British Journal of Cancer. 130(7). 1119–1130. 1 indexed citations
2.
Petővári, Gábor, Szilárd Póliska, Eszter Anna Janka, et al.. (2024). Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFβ-ERK signaling. GeroScience. 46(4). 3581–3597. 4 indexed citations
3.
Petővári, Gábor, Titanilla Dankó, Noémi Nagy, et al.. (2024). mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies. Pathology & Oncology Research. 30. 1611643–1611643. 1 indexed citations
5.
Petővári, Gábor, et al.. (2023). BMP-induced non-canonical signaling is upregulated during autophagy-mediated regeneration in inflamed mesothelial cells. Scientific Reports. 13(1). 10426–10426. 3 indexed citations
6.
Horváth, Anna, Katalin Dezső, Andrea Reszegi, et al.. (2023). SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer. Cancers. 15(7). 2037–2037. 8 indexed citations
7.
Petővári, Gábor, Titanilla Dankó, Henriett Butz, et al.. (2022). Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts. Cancers. 14(16). 3913–3913. 8 indexed citations
9.
Sípos, Ferenc, Titanilla Dankó, Gábor Petővári, et al.. (2022). Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response. Pathology & Oncology Research. 28. 1610322–1610322. 7 indexed citations
10.
Krencz, Ildikó, Titanilla Dankó, Gábor Petővári, et al.. (2022). Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics. International Journal of Molecular Sciences. 23(18). 10587–10587. 5 indexed citations
11.
Karászi, Katalin, Bálint Péterfia, Lilla Turiák, et al.. (2022). SPOCK1 Promotes the Development of Hepatocellular Carcinoma. Frontiers in Oncology. 12. 819883–819883. 9 indexed citations
12.
Dankó, Titanilla, Gábor Petővári, Ildikó Krencz, et al.. (2022). Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting. International Journal of Molecular Sciences. 23(13). 7444–7444. 18 indexed citations
13.
Turiák, Lilla, Tamás Visnovitz, Csaba Cserép, et al.. (2021). Formation of a protein corona on the surface of extracellular vesicles in blood plasma. Journal of Extracellular Vesicles. 10(11). e12140–e12140. 289 indexed citations breakdown →
14.
Dankó, Titanilla, Gábor Petővári, Péter Lőrincz, et al.. (2021). Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. International Journal of Molecular Sciences. 22(15). 8019–8019. 21 indexed citations
15.
Sebestyén, Anna, et al.. (2021). The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues. Cancer and Metastasis Reviews. 40(4). 989–1033. 26 indexed citations
16.
Balogh, Andrea, et al.. (2020). Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro. International Journal of Molecular Sciences. 21(14). 5100–5100. 15 indexed citations
17.
Krencz, Ildikó, Noémi Nagy, Gábor Petővári, et al.. (2020). Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma. Cancers. 12(7). 1947–1947. 8 indexed citations
18.
Petővári, Gábor, Titanilla Dankó, Ildikó Krencz, et al.. (2019). Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells. Pathology & Oncology Research. 26(1). 23–33. 16 indexed citations
19.
Horváth, Gergő, Gábor Petővári, Ildikó Krencz, et al.. (2018). GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas. Journal of Experimental & Clinical Cancer Research. 37(1). 271–271. 30 indexed citations
20.
Dankó, Titanilla, Gábor Petővári, Noémi Nagy, et al.. (2018). The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells. Pathology & Oncology Research. 25(4). 1379–1386. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026